ArticleInvestigational new drugs2021

Absorption of the orally active multikinase inhibitor axitinib as a therapeutic index to guide dose titration in metastatic renal cell carcinoma.

Masahide Fukudo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.